A novel regimen for poor-prognosis or relapsed germ cell tumors

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2007年 / 4卷 / 11期
关键词：
D O I：
10.1038/ncponc0947x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：583 / 583
相关论文
共 50 条
  • [21] BOP/VIP - A NEW PLATINUM-INTENSIVE CHEMOTHERAPY REGIMEN FOR POOR PROGNOSIS GERM-CELL TUMORS
    LEWIS, CR
    FOSSA, SD
    MEAD, G
    HUININK, WT
    HARDING, MJ
    MILL, L
    PAUL, J
    JONES, WG
    RODENBURG, CJ
    CANTWELL, B
    KEIZER, HJ
    VANOOSTEROM, A
    SOUKOP, M
    SPLINTER, T
    KAYE, SB
    ANNALS OF ONCOLOGY, 1991, 2 (03) : 203 - 211
  • [22] Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy
    Fosså, SD
    Kaye, SB
    Mead, GM
    Cullen, M
    de Wit, R
    Bodrogi, I
    van Groeningen, CJ
    De Mulder, PHM
    Stenning, S
    Lallemand, E
    De Prijck, L
    Collette, L
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 716 - 724
  • [23] Phase II trial of dose-dense BEP for intermediate- and poor-prognosis metastatic germ cell tumors.
    Rimmer, Y. L.
    Chester, J. D.
    Stark, D. P.
    Joffe, J. K.
    Shamash, J.
    White, J. D.
    Upton, N.
    Wason, J.
    Parashar, D.
    Williams, M. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] High-dose chemotherapy and autologous hemopoietic stem cell transplantation in patients with poor-prognosis germ cell tumors - single center experience
    Sarosiek, T
    Zolnierek, J
    Langiewicz, P
    Lesniewski-Kmak, K
    Szczylik, C
    Rzepecki, P
    Jedrzejczak, W
    BONE MARROW TRANSPLANTATION, 2003, 31 : S192 - S193
  • [25] Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy
    Shamash, Jonathan
    Mee, Matthew
    Sarker, Shah-Jalal
    Wilson, Peter
    Ansell, Wendy
    Greenwood, Michelle
    Berney, Dan
    Alifrangis, Constantine
    BJU INTERNATIONAL, 2020, 125 (06) : 843 - 852
  • [26] IMPROVED OUTCOME FOR POOR-PROGNOSIS METASTATIC GERM CELL CANCER: A SINGLE CENTER EXPERIENCE IN JAPAN
    Yamada, Shigeyuki
    Saito, Hideo
    Kaiho, Yasuhiro
    Ito, Akihiro
    Ishidoya, Shigeto
    Arai, Yoichi
    JOURNAL OF UROLOGY, 2010, 183 (04): : E328 - E329
  • [27] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH POOR-PROGNOSIS NONSEMINOMATOUS GERM-CELL TUMORS
    BARNETT, MJ
    COPPIN, CML
    MURRAY, N
    NEVILL, TJ
    REECE, DE
    KLINGEMANN, HG
    SHEPHERD, JD
    NANTEL, SH
    SUTHERLAND, HJ
    PHILLIPS, GL
    BRITISH JOURNAL OF CANCER, 1993, 68 (03) : 594 - 598
  • [28] Poor prognosis germ cell tumors: Current status and future directions
    Toner, GC
    Motzer, RJ
    SEMINARS IN ONCOLOGY, 1998, 25 (02) : 194 - 202
  • [29] Promising novel therapies for relapsed and refractory testicular germ cell tumors
    Kozakova, Kristyna
    Mego, Michal
    Cheng, Liang
    Chovanec, Michal
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (01) : 53 - 69
  • [30] NEW APPROACHES TO THE MANAGEMENT OF POOR PROGNOSIS NONSEMINOMATOUS GERM-CELL TUMORS
    GRIGG, A
    MCKENDRICK, J
    FOX, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (06): : 679 - 684
12345